Importance Intravenous magnesium sulfate administered to pregnant individuals before birth
at less than 30 weeks' gestation reduces the risk of death and cerebral palsy in their …

Background Magnesium sulphate is extensively used in obstetrics for the treatment and
prevention of eclampsia. A recent meta‐analysis has shown that magnesium sulphate is an …

OBJECTIVE: To evaluate the association of duration of magnesium sulfate infusion with
stillbirth or death, cerebral palsy, and select adverse maternal and neonatal outcomes …

[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm
newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective …

We conducted a systematic review and metaanalysis of randomized controlled trials to
determine whether magnesium sulfate administered to women at risk of preterm delivery …

Cerebral palsy (CP) remains the most significant neurological disorder associated with
preterm birth. It disrupts quality of life and places huge cost burdens on society. Antenatal …

Very preterm infants have high rates of neurological impairments and disabilities. These
rates have not diminished as the survival rates have improved. Basic science research …

Objective To evaluate a slower (compared with a standard) infusion rate of the loading dose
of magnesium sulphate for preterm fetal neuroprotection as a strategy to reduce maternal …

Antenatal magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Antenatal
magnesium sulfate and neuroprotection : Current Opinion in Pediatrics Log in or Register …

Prevention of neurologic disability associated with preterm birth is one of the major
challenges in current perinatal medicine. Magnesium sulfate (MgSO4), the focus of this …